Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 7/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | HPRT1 | P00492 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22155523 | 0.99 | ABCG2 (0.40) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL24282295 | 0.97 | ABCG2 (0.40) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL22155062 | 0.97 | ABCG2 (0.42) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL22155156 | 0.95 | ABCG2 (0.38) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL22155128 | 0.95 | ABCG2 (0.38) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL24362942 | 0.93 | CYP1A1 (0.41) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL22155076 | 0.93 | ABCG2 (0.46) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL22155571 | 0.93 | ABCG2 (0.41) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL22155590 | 0.93 | ABCG2 (0.41) | ABCG2PAX8CYP1A1CYP1A2FYN | |
| SCHEMBL22155408 | 0.92 | ABCG2 (0.38) | ABCG2PAX8CYP1A1CYP1A2FYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11296282-B2 | Organic compound and organic electroluminescence device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2022-04-05 | — | — | US | disclosed |
| US-20200203632-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11296282-B2 | Organic compound and organic electroluminescence device using the same | SLCO4C1, EML4, SLCO2A1 | ABCG2 433/4885PAX8 1290/4885CYP1A1 884/4885 |
| US-20200203632-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SLCO4C1, EML4, SLCO2A1 | ABCG2 433/4885PAX8 1290/4885CYP1A1 884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.